Skip to content
Gilgamesh Pharmaceuticals logo

Gilgamesh Pharmaceuticals

Gilgamesh Pharmaceuticals is a YC Summer 2020 (S20) company. Based in New York, NY, USA; Remote. Team of 15.

  • Therapeutics
  • Psychedelics
  • Mental Health

About Gilgamesh Pharmaceuticals

GPAgent's own fund-neutral profile, written from public information. Updated Oct 5, 2026.

Summary

Gilgamesh Pharmaceuticals develops novel chemical entities for mental health conditions, advancing candidates through clinical-stage trials. The company combines medicinal chemistry, neuroscience, and drug development to create proprietary psychedelic-derived therapeutics. This work replaces reliance on legacy psychiatric drugs with purpose-built molecules designed from the ground up for mental health indications.

From the Y Combinator listing

How Gilgamesh Pharmaceuticals describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

Gilgamesh Pharmaceuticals, a Clinical stage biotechnology company…

Gilgamesh is a pioneering, clinical stage mental health science-focused biotechnology company. We have a disciplined focus on developing innovative new chemical entities (NCEs) leveraging a unique combination of medicinal chemistry, intellectual property strategy, neuroscience & neurobiology, and drug development expertise. We are an experienced team, with proven success in biotech exits and inventions.

Facts

Industry
Healthcare / Healthcare -> Drug Discovery and Delivery
Location
New York, NY, USA; Remote
Team size
15
Status
Active
Stage
Early

Founders (3)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works